What is the CVR number of AVP BioPharma Consult ApS?

AVP BioPharma Consult ApS is registered with CVR / Virk under CVR 37770426.

What is the revenue of AVP BioPharma Consult ApS?

AVP BioPharma Consult ApS reported revenue of DKK 1,2M in 2025.

How many employees does AVP BioPharma Consult ApS have?

AVP BioPharma Consult ApS employs 1 people as of the latest annual report.

Who is the CEO of AVP BioPharma Consult ApS?

Anders Vagnø Pedersen is Chief Executive Officer of AVP BioPharma Consult ApS, in role since 2016.

Where is AVP BioPharma Consult ApS headquartered?

AVP BioPharma Consult ApS's registered address is Teknikerbyen 5, 1..

AVP BioPharma Consult ApS

APSActive

CVR 37770426Teknikerbyen 5, 1.Research and experimental development on natural sciences and engineering · NACE 7210Est. 20161 employeeswww.avp-biopharma.com

Revenue 2025

DKK 1,2M

+7% vs 2024

EBITDA margin

26.1%

+4% vs 2024

Equity ratio

72.2%

Financial strength

Net profit 2025

DKK 247K

+4% vs 2024

EBITDA — year on yearDKK millions

Key figuresAnnual report 2025

Revenue	DKK 1,2M	+7%
EBITDA	DKK 326K	+4%
Net profit	DKK 247K	+4%
Total assets	DKK 444K	-12%
Equity	DKK 321K	-1%
Employees	1	—

Item	2021	2022	2023	2024	2025
Revenue	1.201	1.125	1.009	1.169	1.249
Staff expenses	-861	-932	-864	-857	-923
EBITDA	341	194	145	312	326
Depreciation & amort.	-6	-0	-5	-0	-0
EBIT	334	194	140	312	326
Net financials	1	-3	-2	-5	-6
Profit before tax	335	191	138	307	320
Tax	74	42	32	69	72
Net profit	261	148	106	238	247

Item	2021	2022	2023	2024	2025
Total assets	516	498	387	504	444
Equity	346	294	225	323	321
Long-term debt	0	0	0	0	0
Short-term debt	170	203	162	181	123
Total debt	170	203	162	181	123

Name	Role	Member since
Current (1)
AV Anders Vagnø Pedersen Chief Executive Officer	Chief Executive Officer	2016

Shareholder	Type	Ownership	Votes	Since
AVP Holdings ApS	Company	100%	100%	2016

Person	Role here	Other companies
Anders Vagnø Pedersen	Chief Executive Officer	0 companies

AVP BioPharma Consult ApS

APSActive

CVR 37770426Teknikerbyen 5, 1.Research and experimental development on natural sciences and engineering · NACE 7210Est. 20161 employeeswww.avp-biopharma.com

Revenue 2025

DKK 1,2M

+7% vs 2024

EBITDA margin

26.1%

+4% vs 2024

Equity ratio

72.2%

Financial strength

Net profit 2025

DKK 247K

+4% vs 2024

EBITDA — year on yearDKK millions

Key figuresAnnual report 2025

Revenue	DKK 1,2M	+7%
EBITDA	DKK 326K	+4%
Net profit	DKK 247K	+4%
Total assets	DKK 444K	-12%
Equity	DKK 321K	-1%
Employees	1	—